These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2590613)

  • 1. Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.
    Routledge PA; Stargel WW; Barchowsky A; Wagner GS; Shand DG
    Br J Clin Pharmacol; 1989 Nov; 28(5):593-7. PubMed ID: 2590613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.
    Prescott LF; Adjepon-Yamoah KK; Talbot RG
    Br Med J; 1976 Apr; 1(6015):939-41. PubMed ID: 1268491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
    Nattel S; Gagne G; Pineau M
    Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of lignocaine.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
    Upward JW; Holt D; Emery P; Akhras F; Jackson G
    Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between plasma lignocaine levels and induced haemodynamic changes.
    Binnion PF; Murtagh G; Pollock AM; Fletcher E
    Br Med J; 1969 Aug; 3(5667):390-2. PubMed ID: 5797780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
    Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
    Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A free lignocaine index as a guide to unbound drug concentration.
    Routledge PA; Lazar JD; Barchowsky A; Stargel WW; Wagner GS; Shand DG
    Br J Clin Pharmacol; 1985 Dec; 20(6):695-8. PubMed ID: 4092000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
    Barchowsky A; Shand DG; Stargel WW; Wagner GS; Routledge PA
    Br J Clin Pharmacol; 1982 Mar; 13(3):411-5. PubMed ID: 7059443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Logical approach to lignocaine therapy.
    Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F
    Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.
    Silke B; Frais MA; Verma SP; Reynolds GW; Hafizullah M; Kalra PA; Jackson NC; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):707-14. PubMed ID: 3105568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood levels of lignocaine after intramuscular administration to patients with proven or suspected acute myocardial infarction.
    Rydén L; Wasir H; Conradsson TB; Olsson B
    Br Heart J; 1972 Oct; 34(10):1012-7. PubMed ID: 5086967
    [No Abstract]   [Full Text] [Related]  

  • 13. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations on intravenous administration of lignocaine in patients with myocardial infarction.
    Campbell NP; Kelly JG; Adgey AA; McDevitt DG; Pantridge JF
    Br Heart J; 1978 Dec; 40(12):1371-5. PubMed ID: 737094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration.
    Sheridan DJ; Crawford L; Rawlins MD; Julian DG
    Lancet; 1977 Apr; 1(8016):824-5. PubMed ID: 67335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple lignocaine regimen for transit to hospital after myocardial infarction.
    Barber JM; Boyle DM; Hussain Z; McDevitt DG
    Br Heart J; 1977 Dec; 39(12):1361-3. PubMed ID: 603738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in lignocaine disposition during long-term infusion in patients with acute ventricular arrhythmias.
    Thomson AH; Kelman AW; de Vane PJ; Hillis WS; Whiting B
    Ther Drug Monit; 1987 Sep; 9(3):283-91. PubMed ID: 3672571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lidocaine elimination and dose adjustment in acute heart infarct and heart insufficiency].
    Kettner W; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Jul; 39(14):335-42. PubMed ID: 6485432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lignocaine disposition in blood in epilepsy.
    Routledge PA; Stargel WW; Finn AL; Barchowsky A; Shand DG
    Br J Clin Pharmacol; 1981 Nov; 12(5):663-6. PubMed ID: 7332731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.